The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index; none of the 62 sources its claims cite is checked for support yet.
Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial
Open accessAbstract
Background: The aims of the study were to determine the prevalence of cardiometabolic risk factors and establish the proportion of people with psychosis meeting criteria for the metabolic syndrome (MetS). The study also aimed to identify the key lifestyle behaviours associated with increased risk of the MetS and to investigate whether the MetS is associated with illness severity and degree of functional impairment. Method: Baseline data were collected as part of a large randomized controlled trial (IMPaCT RCT). The study took place within community mental health teams in five Mental Health NHS Trusts in urban and rural locations across England. A total of 450 randomly selected out-patients, aged 18–65 years, with an established psychotic illness were recruited. We ascertained the prevalence rates of cardiometabolic risk factors, illness severity and functional impairment and calculated rates of the MetS, using International Diabetes Federation (IDF) and National Cholesterol Education Program Third Adult Treatment Panel criteria. Results: High rates of cardiometabolic risk factors were found. Nearly all women and most men had waist circumference exceeding the IDF threshold for central obesity. Half the sample was obese (body mass index ≥ 30 kg/m 2) and a fifth met the criteria for type 2 diabetes mellitus. Females were more likely to be obese than males (61% v. 42%, p < 0.001). Of the 308 patients with complete laboratory measures, 57% (n = 175) met the IDF criteria for the MetS. Conclusions: In the UK, the prevalence of cardiometabolic risk factors in individuals with psychotic illnesses is much higher than that observed in national general population studies as well as in most international studies of patients with psychosis.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
In baseline data from the IMPaCT RCT of 450 UK outpatients with established psychotic illness, cardiometabolic risk factors were highly prevalent, with 56.8% of those with complete measures meeting IDF criteria for metabolic syndrome. Central obesity, obesity, diabetes/glucose dysregulation, hypertension, dyslipidaemia, and smoking were common and exceeded general-population comparisons.
Key findings
- Of 308 patients with complete measures, IDF metabolic syndrome prevalence was 56.8% (175/308); ATP-III prevalence was 56.2% (173/308). Central obesity was present in 83% overall, including 95% of women (160/169) versus 74% of men (167/227).
- Obesity (BMI ≥30 kg/m²) was 50% (192/398), and women were more likely to be obese than men (61% v. 42%, p < 0.001). Type 2 diabetes criteria were met by 20% (66/330), with an additional 30% showing glucose dysregulation; hypertension was 54% (214/398), dyslipidaemia 89% (305/342), and smoking 62% (268/432).
- High-intensity physical activity was reported by 12% (54) and was associated with lower metabolic syndrome rates (15/41 v. 160/267, p = 0.004). PANSS scores were not significantly associated with individual cardiometabolic risk factors, while greater functional impairment on GAF was associated with obesity, diabetes, and hypertension, and higher MADRS scores with obesity.
- White patients had higher IDF metabolic syndrome rates than black African or Caribbean patients (114/171 v. 47/101, p = 0.001); there was no gender difference in metabolic syndrome, no duration-of-illness effect, and no excess risk with clozapine or olanzapine.
Methods
- Baseline cross-sectional analysis within the IMPaCT randomized controlled trial; 450 randomly selected outpatients aged 18–65 with established psychotic illness were recruited from community mental health teams in five Mental Health NHS Trusts across urban and rural England.
- Data included sociodemographic and clinical measures, PANSS, GAF, MADRS, AUDIT, smoking/cannabis/urine drug screen, DINE, and IPAQ; physical measures included height, weight, blood pressure, waist circumference, and fasting blood samples. Metabolic syndrome was defined using IDF and NCEP ATP-III criteria.
- Analyses used descriptive statistics, Student’s t tests for parametric data, and χ² tests for categorical variables; tests were two-sided with p ≤ 0.05 considered significant.
Limitations
- Stated: cross-sectional design, no control group, no adjustment for socioeconomic deprivation; missing metabolic and clinical data may have introduced selection bias; duration of illness was self-reported; no data on duration or previous antipsychotic treatment; first-episode psychosis and primary care-only patients were excluded.
- Stated: recruitment was England-wide but predominantly from Greater London, and findings may not generalize to patients with these diagnoses managed only in primary care.
- Evident: baseline cross-sectional data cannot establish causality or temporal ordering; metabolic syndrome prevalence is based on 308/450 participants with complete measures, so complete-case analysis may affect representativeness.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
58 Own result · 47 Not checked yet · 13 Own method · 7 Own interpretation
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“White patients had higher serum triglycerides than black African or Caribbean patients (mean difference = 0.89, p < 0.003).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Ethnicity
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Those with IDF MetS were older (mean age = 44.68 years, s.d. = 9.8) than those without IDF MetS (42.12 years, s.d. = 10.4) (t = −2.28, p = 0.028).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > MetS
plaincorrelationaln = 308 ·- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of the 13 individuals who were not prescribed antipsychotics and who had complete measures to allow for MetS status to be confirmed, eight met the criteria for IDF MetS.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > MetS
plainn = 13- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this group, the prevalence of IDF MetS was 56.8% (n = 175/308).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > MetS
plainn = 175- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Female patients had significantly higher BMIs than males [t = 2.329, degrees of freedom (df) = 426, p < 0.020].”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Cardiovascular risk factors (see Table 3)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of the subjects, 48% (192/398) were obese (BMI > 30 kg/m2).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Cardiovascular risk factors (see Table 3)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Also, there was no excess of other cardiometabolic risk factors [dyslipidaemia (p = 0.418), hypertension (p = 0.546) and diabetes (p = 0.463)].”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Cardiovascular risk factors (see Table 3)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The prevalence of the MetS as defined by the ATP-III criteria was 56.2% (n = 173/308).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > MetS
plainn = 173- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A consistent relationship was found between cardiometabolic risk factors and functional impairment as measured by GAF scores.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Psychopathology and cardiometabolic risk factors (see Table 4)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The prescription of either olanzapine or clozapine (n = 191) (which are the antipsychotic medications traditionally associated with the highest risk of metabolic dysfunction) was not associated with an increased rate of obesity (n = 80, 42%) compared with those not prescribed either dibenzodiazepine (n = 113, 54%) (χ2 = 1.270, df = 1, p = 0.153).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Cardiovascular risk factors (see Table 3)
plainn = 191- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 37
- Probably not a substantial claim. 44
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, there were no significant differences in overall rates of dyslipidaemia (p = 0.545), hypertension (p = 0.101), diabetes (p = 0.298) and obesity (BMI > 30 kg/m2) (p = 0.140).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Ethnicity
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In respect of ethnicity, 55% (n = 239) were of Caucasian ethnicity, while 33% (n = 143) were of black African or black Caribbean ethnicity, with 7% (n = 27) of Asian ethnicity and 5% (n = 22) of mixed ethnicity.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results
plainn = 450- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Hypertension was present in 214/398 (54%), of whom 62 were on anti-hypertensive therapy.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Cardiovascular risk factors (see Table 3)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no relationship between duration of psychotic illness and any of obesity (BMI > 30 kg/m2) (t = 0.410, df = 329, p = 0.682), hypertension (t = −1.346, p = 0.179), dyslipidaemia (t = −0.144, p = 0.886) or presence of diabetes mellitus (t = −0.992, df = 251, p = 0.322).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Psychopathology and cardiometabolic risk factors (see Table 4)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Mean age was 43.6 years (s.d. = 10.1) and mean duration of illness was 15.7 years (s.d. = 10.3); 57% (n = 257) were male.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results
plainn = 449- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Mean age was 43.6 years (s.d. = 10.1) and mean duration of illness was 15.7 years (s.d. = 10.3); 57% (n = 257) were male.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results
plainn = 257- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of the participants, 30% (n = 127) were prescribed clozapine and 16% (n = 70) olanzapine.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results
plainn = 127- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no significant difference between mean BMI (p = 0.241) and waist circumference (p = 0.437) when stratified by geographical location (by borough).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Cardiovascular risk factors (see Table 3)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of the participants, 75% (n = 321) were treated with second-generation (atypical) antipsychotics (including clozapine and olanzapine), 16% (n = 71) were treated with first-generation antipsychotics and 8% (n = 36) were treated with a combination of antipsychotics.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results
plainn = 321- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of patients screened, 39% (1043/2663) met the inclusion criteria, with the majority excluded for not meeting the diagnostic inclusion criterion (though the exact percentage excluded by each exclusion criterion is not known).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Method > Study design
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no difference in duration of illness (p = 0.358), or the use of clozapine (p = 0.282) or olanzapine (p = 0.303) in those with IDF MetS compared with those without.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > MetS
plainn = 308- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of the subjects, 62% (268/432) smoked tobacco, smoking an average of 18.2 (s.d. = 11.6) cigarettes per day.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Cardiovascular risk factors (see Table 3)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Engaging in high levels of physical activity was associated with lower rates of obesity (χ2 = 20.944, p < 0.0001) and dyslipidaemia (χ2 = 17.537, p = 0.001) compared with low-intensity physical activity.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Lifestyle measures
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of the respondents, 28% (n = 68/291) had hazardous/harmful alcohol use (AUDIT score ≥ 8), while the alcohol intake of a further 4% (n = 12/291) indicated the need for diagnostic evaluation for alcohol dependence syndrome (AUDIT score ≥ 20).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Drug and alcohol use
plainn = 68- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of the participants, 3% (n = 13/439) were cocaine or amphetamine users, 1.4% (n = 6) reported ongoing crack cocaine use and less than 1% (n = 3) reported using ecstasy.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Drug and alcohol use
plainn = 13- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of the participants, 44% (n = 196) were engaging in low-intensity physical activity, 44% (n = 200) engaged in moderate-intensity physical activity, while 12% (n = 54) participated in high-intensity physical activity.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Lifestyle measures
plainn = 196- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of the participants, 23% (102/435) had a high saturated fat intake score on the DINE, 29.7% (129/435) had a medium fat intake, while 47% (204/435) had a low saturated fat intake; 51% of the participants (n = 210) had a low fibre intake, with only 25% (n = 102) reporting a high fibre intake.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Lifestyle measures
plainn = 210- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of the respondents, 18% (n = 76/422) were current cannabis users, with 52 people identified through the Timeline Follow-Back procedure and a further 24 identified through a cannabinoid-positive urinary drug screen.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Drug and alcohol use
plainn = 76- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“A recent meta-analysis has demonstrated that the pooled relative risk of mortality among those with psychoses is 2.54 (2.35–2.75) times that of the general population, and higher rates of mortality for those with psychoses when compared with depressive and anxiety disorders (Walker et al. 2015).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Introduction
What the sources say
- Not checked yetcites Walker et al. 2015
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“A recent meta-analysis of international studies reported prevalence rates of 44% for central obesity, 19.5% for hyperglycaemia, 10.9% for diabetes, 39% for hypertension and 39% for dyslipidaemias, with rates increasing with age (Mitchell et al. 2013).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Introduction
What the sources say
- Not checked yetcites Mitchell et al. 2013
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“On meta-analysis, a third of patients with schizophrenia have the MetS, with this proportion increasing with duration of illness (Mitchell et al. 2013).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Introduction
What the sources say
- Not checked yetcites Mitchell et al. 2013
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“while the deficit syndrome (i.e. negative symptoms of psychosis that are present as enduring traits) in schizophrenia is in itself associated with higher CVD risk (Arango et al. 2011).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Introduction
What the sources say
- Not checked yetcites Arango et al. 2011
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Similar rates of the MetS have been observed in bipolar disorder (37%) (Vancampfort et al. 2013a) and schizo-affective disorder (27–42%) (Basu et al. 2004; Bobes et al. 2012), although recently the Second Australian National Survey of Psychosis reported higher rates of 61% in those with psychotic disorders, suggesting an increasing prevalence with time (Morgan et al. 2014).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Introduction
What the sources say
- Not checked yetcites Vancampfort et al. 2013a
- Not checked yetcites Basu et al. 2004
- Not checked yetcites Bobes et al. 2012
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Individuals with the MetS have a 3- to 6-fold increased risk of developing type 2 diabetes mellitus (Hanley et al. 2005; De Hert et al. 2011) and a 2- to 6-fold risk of mortality due to cardiovascular disease (CVD) (Hanley et al. 2005).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Introduction
What the sources say
- Not checked yetcites Hanley et al. 2005
- Not checked yetcites De Hert et al. 2011
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Individuals with the MetS have a 3- to 6-fold increased risk of developing type 2 diabetes mellitus (Hanley et al. 2005; De Hert et al. 2011) and a 2- to 6-fold risk of mortality due to cardiovascular disease (CVD) (Hanley et al. 2005).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Introduction
What the sources say
- Not checked yetcites Hanley et al. 2005
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“The diagnosis of a psychotic illness such as schizophrenia or bipolar disorder is associated with a reduced life expectancy of 15–25 years, mostly due to increased cardiovascular deaths (Saha et al. 2007; Kilbourne et al. 2009; Brown et al. 2010; Chang et al. 2011).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Introduction
What the sources say
- Not checked yetcites Saha et al. 2007
- Not checked yetcites Kilbourne et al. 2009
- Not checked yetcites Brown et al. 2010
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Slightly higher MetS rates of 34% are seen in multi-episode patients (Vancampfort et al. 2013b) while the deficit syndrome (i.e. negative symptoms of psychosis that are present as enduring traits) in schizophrenia is in itself associated with higher CVD risk (Arango et al. 2011).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Introduction
What the sources say
- Not checked yetcites Vancampfort et al. 2013b
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Encouragingly, various UK medical Royal colleges have recently agreed joint management strategies for CVD risk in psychotic illnesses (Lester et al. 2014).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Introduction
What the sources say
- Not checked yetcites Lester et al. 2014
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Participants’ mental health status was measured using the Positive And Negative Syndrome Scale (PANSS; Kay et al. 1989), the Global Assessment of Functioning (GAF; American Psychiatric Association, 2002) and the Montgomery–Åsberg Depression Rating Scale (MADRS; Montgomery & Åsberg, 1979).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Method > Clinical and sociodemographic variables
What the sources say
- Not checked yetcites Kay et al. 1989 source
- Not checked yetcites American Psychiatric Association, 2002
- Not checked yetcites Montgomery & Åsberg, 1979
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“It is possible to prevent the emergence of CVD risk in psychosis with the use of psychosocial interventions in the short term, though this is not sustained once the intervention is discontinued (Alvarez-Jimenez et al. 2010).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Introduction
What the sources say
- Not checked yetcites Alvarez-Jimenez et al. 2010
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Data for all measures were collected through face-to-face interviews conducted by trained research assistants.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Method > Clinical and sociodemographic variables
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The Dietary Instrument for Nutrition Education (DINE; Roe et al. 1994) was used to assess the dietary patterns of participants over the past week.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Method > Cardiometabolic risk factors
What the sources say
- Not checked yetcites Roe et al. 1994
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Potential participants were identified through their care-coordinator. All care-coordinators in participating CMHTs were approached in a random sequence and invited to participate. Patients on each participating care coordinator's caseload, meeting the inclusion criteria, were likewise approached in a random order.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Method > Study design
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“although recently the Second Australian National Survey of Psychosis reported higher rates of 61% in those with psychotic disorders, suggesting an increasing prevalence with time (Morgan et al. 2014).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Introduction
What the sources say
- Not checked yetcites Morgan et al. 2014
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“As both serum glucose and triglycerides are affected by recent food ingestion, we took fasting blood samples.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Method > Cardiometabolic risk factors
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Height, weight and blood pressure (BP) were measured using standardized techniques.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Method > Cardiometabolic risk factors
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“The International Physical Activity Questionnaire was used to measure the intensity of physical activity (high, moderate, low) and the duration of physical activities over the previous week (Craig et al. 2003).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Method > Cardiometabolic risk factors
What the sources say
- Not checked yetcites Craig et al. 2003
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Current alcohol, smoking and cannabis use was recorded using the following measures: the Alcohol Use Disorders Identification Test (AUDIT; Saunders et al. 1993); the Nicotine Dependence Questionnaire (Fagerstrom, 1978; Fagerstrom & Schneider, 1989); Timeline Follow-Back (Sobell & Sobell, 1992); and a urine drug screen.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Method > Clinical and sociodemographic variables
What the sources say
- Not checked yetcites Saunders et al. 1993
- Not checked yetcites Fagerstrom, 1978
- Not checked yetcites Fagerstrom & Schneider, 1989
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Waist circumference was measured at the umbilicus with the patient standing.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Method > Cardiometabolic risk factors
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The BP values presented are the second BP measurements, taken after an interval of 5 min.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Method > Cardiometabolic risk factors
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The study took place in community mental health teams (CMHTs) in five Mental Health NHS Trusts, covering urban (Lambeth, Southwark, Lewisham, Croydon, Greenwich, Bexley, Bromley) and rural (Staffordshire, Somerset and Sussex) boroughs across England (Gaughran et al. 2013).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Method > Study design
What the sources say
- Not checked yetcites Gaughran et al. 2013
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Strategies do exist to manage established cardiometabolic risk factors (Lester et al. 2014), but despite this, a recent UK national audit reported screening rates for metabolic side effects of antipsychotic medication of only 11% (Barnes et al. 2007).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Introduction
What the sources say
- Not checked yetcites Lester et al. 2014
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The recent Schizophrenia Commission Report (UK) highlighted the disparity of care for individuals with psychosis and emphasized the need for improved physical health intervention (Schizophrenia Commission, 2012).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Introduction
What the sources say
- Not checked yetcites Schizophrenia Commission, 2012
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“This meta-analysis found a lack of homogeneity in the distribution of MetS prevalence across individual studies.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
What the sources say
- Not checked yetcites Mitchell et al. 2013
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Of note, in the US Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study, the PANSS mean total score of 75.9 was higher than in IMPaCT (51.2) – with lower NCEP ATP-III MetS rates of 36% in CATIE compared with the ATP-III MetS rate of 56% in IMPaCT, meaning that our higher rates of cardiometabolic risk are not a result of illness severity (Meyer et al. 2005).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
What the sources say
- Not checked yetcites Meyer et al. 2005
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“As exercise is linked to greater longevity in the general population (Paffenbarger et al. 1993; Manson et al. 2002), it is likely that greater emphasis on engaging in physical activity among those with severe mental illnesses (SMI) would help reduce mortality risk (Vancampfort et al. 2010).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
What the sources say
- Not checked yetcites Paffenbarger et al. 1993
- Not checked yetcites Manson et al. 2002
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“This lack of difference is especially interesting in light of the evidence that patients with schizophrenia treated with clozapine have the least reduction in life expectancy of all patients with schizophrenia (Tiihonen et al. 2009; Hayes et al. 2014).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
What the sources say
- Not checked yetcites Tiihonen et al. 2009
- Not checked yetcites Hayes et al. 2014
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Of the study population, 50% had evidence of glucose dysregulation, including 20% of the sample with type 2 diabetes, which is much higher than the rate in the general UK population (International Diabetes Federation, 2013).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
What the sources say
- Not checked yetcites International Diabetes Federation, 2013
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the UK, the prevalence of cardiometabolic risk factors in individuals with psychotic illnesses is much higher than that observed in national general population studies as well as in most international studies of patients with psychosis.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Abstract > Conclusions
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The sample of 450 randomly selected out-patients with established psychosis from community mental health teams in England is representative of people with psychotic illnesses in the UK.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Strengths of this study include a sample of randomly selected individuals with psychosis from diverse ethnic backgrounds and the mix of urban and rural locations adding to the generalizability of the study findings.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This cohort of individuals with established psychosis had a high prevalence of both individual cardiometabolic risk factors and of the MetS.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“A high proportion of this sample was prescribed dibenzodiazepines, which are associated with early emergence of cardiometabolic risk factors (Howes et al. 2004; Nielsen et al. 2010).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
What the sources say
- Not checked yetcites Howes et al. 2004
- Not checked yetcites Nielsen et al. 2010
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“A recent 11-year follow-up of 517 people with schizophrenia showed an overall standardized mortality ratio of 2.80, smoking being a very strong predictor of death (relative risk of 4.66) (Dickerson et al. 2014).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
What the sources say
- Not checked yetcites Dickerson et al. 2014
boostedcorrelationaln = 517- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“However, findings from a systematic review have demonstrated that people with schizophrenia want to stop smoking and that it is possible to help them to do so (Banham & Gilbody, 2010)”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
What the sources say
- Not checked yetcites Banham & Gilbody, 2010
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“As exercise is linked to greater longevity in the general population (Paffenbarger et al. 1993; Manson et al. 2002), it is likely that greater emphasis on engaging in physical activity among those with severe mental illnesses (SMI) would help reduce mortality risk (Vancampfort et al. 2010).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
What the sources say
- Not checked yetcites Vancampfort et al. 2010
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“Similar rates of cardiometabolic risk to what we found have been identified in a large Australian prevalence survey in psychosis, where rates of abdominal obesity greater than 80% were found, as well as comparable rates of the MetS, dyslipidaemia and hypertension (Galletly et al. 2012).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
What the sources say
- Not checked yetcites Galletly et al. 2012
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Limitations of the study include the cross-sectional design, and the lack of a control group.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Smoking not only increases the risk of early death, but also complicates treatment, in that the hydrocarbons in cigarette smoke accelerate the metabolism of dibenzodiazepines, clozapine and olanzapine (Rostami-Hodjegan et al. 2004).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
What the sources say
- Not checked yetcites Rostami-Hodjegan et al. 2004
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Of our participants, 56.8% met criteria for the MetS, greatly exceeding the international figure of 34% described in a recent meta-analysis of the MetS in schizophrenia (Mitchell et al. 2013).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
What the sources say
- Not checked yetcites Mitchell et al. 2013
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Practice in in-patient psychiatric services has improved with the advent of incentivization and of shared guidelines for CVD risk management in psychosis such as the Lester Cardiometabolic Health Resource (Lester et al. 2014).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Conclusion
What the sources say
- Not checked yetcites Lester et al. 2014
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Our study population, compared with this primary care-only population, may be functionally or symptomatically more impaired; and antipsychotic prescribing patterns may be different – for instance, clozapine is rarely prescribed in primary care.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“We have no data on duration of antipsychotic treatment and previous antipsychotic treatments used over the longitudinal course of an individual's illness, both of which are confounding factors that could potentially make an impact on an individual's cardiometabolic risk factors.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Although central obesity is known to be the best predictor of morbidity and mortality (Zimmet et al. 2001), waist circumference has not to date been routinely measured in people with psychosis, although it has now been included in the latest National Institute of Health and Clinical Excellence (2014) guidelines for schizophrenia.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Conclusion
What the sources say
- Not checked yetcites Zimmet et al. 2001
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“We have not adjusted for the effect of socio-economic deprivation.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“A recent Scottish paper noted an excess of mortality in SMI linked to deprivation, although this effect was not evident for deaths due to cerebrovascular disease or CVD (Langan Martin et al. 2014).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
What the sources say
- Not checked yetcites Langan Martin et al. 2014
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The missing data from metabolic measures and clinical assessment scales may have introduced a selection bias into the study, but it is not obvious what effect such a bias would result in.”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
The sample of 450 randomly selected out-patients with established psychosis from community mental health teams in England is representative of people with psychotic illnesses in the UK.
“A total of 450 randomly selected out-patients, aged 18–65 years, with an established psychotic illness were recruited.”
The paper relies on this without support.
Diagnoses extracted from clinical notes accurately reflect ICD-10 criteria for psychotic illness.
“Diagnoses were based on ICD-10 diagnostic criteria and were extracted from the documented diagnosis in the clinical notes at the time of recruitment.”
The paper relies on this without support.
Waist circumference has not to date been routinely measured in people with psychosis.
“Although central obesity is known to be the best predictor of morbidity and mortality (Zimmet et al. 2001), waist circumference has not to date been routinely measured in people with psychosis, although it has now been included in the latest National Institute of Health and Clinical Excellence (2014) guidelines for schizophrenia.”
The paper relies on this without support.
First-episode psychosis (FEP) patients have different cardiovascular disease (CVD) profiles in the early stages of psychosis.
“The exclusion of FEP patients from this study recognizes the different CVD profiles in the early stages of psychosis.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This finding warrants further investigation, but may be related to a greater propensity to obesity and central obesity in women with SMI compared to men 32 , since central obesity is a significant risk factor for hyperglycaemia.”
From Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis (2016) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Cardiovascular risk factors (see Table 3)
“Fasting glucose, mmol/l (≥5.6 mmol/l) | 322 | 31 (27.7–38.4)”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Cardiovascular risk factors (see Table 3)
“5.9 (2.3)/44 | 6.0 (3.3)/35”
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Lifestyle measures
“lower rates of the MetS were found in those with high-intensity physical activity (n = 15/41), compared with those engaging in low-intensity physical activity (n = 160/267)”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Lifestyle measures
“44% (n = 196) were engaging in low-intensity physical activity”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“Of the respondents, 28% (n = 68/291) had hazardous/harmful alcohol use (AUDIT score ≥ 8)”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Drug and alcohol use
Reported 28 · recomputed 23.367698
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Cardiovascular risk factors (see Table 3)
“Female patients had significantly higher BMIs than males [t = 2.329, degrees of freedom (df) = 426, p < 0.020].”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Cardiovascular risk factors (see Table 3)
“Body mass index, kg/m2 (> 30 kg/m2) | 398”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Cardiovascular risk factors (see Table 3)
“LDL-cholesterol, mmol/l (≥3.0 mmol/l) | 303 | 51 (45.2–56.4) | 3.0 (0.1) (0.3–6.3)”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Cardiovascular risk factors (see Table 3)
“3.0 (1.0)/50 | 3.1 (1.0)/52”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Cardiovascular risk factors (see Table 3)
“Of the subjects, 48% (192/398) were obese (BMI > 30 kg/m2).”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Cardiovascular risk factors (see Table 3)
“Body mass index, kg/m2 (> 30 kg/m2) | 398 | 50 (44–55)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Discussion
“we did find associations between increased functional impairment and obesity, diabetes and hypertension”
§ Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial > Results > Psychopathology and cardiometabolic risk factors (see Table 4)
“56.7 (12.7) | 1.653/0.099”
Citations
Cites
International physical activity questionnaire: 12-country reliability and validity
CRAIG, C. L., MARSHALL, A. L., SJ??STR??M, M., BAUMAN, A. E., BOOTH, M. L., AINSWORTH, B. E., PRATT, M., EKELUND, U., YNGVE, A., SALLIS, J. F., et al. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000078924.61453.fb · Cited by 21,619 · cited 1×
“The International Physical Activity Questionnaire was used to measure the intensity of physical activity (high, moderate, low) and the duration of physical activities over the previous week (Craig et al. 2003).”
MethodA new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · cited 1×
“Participants’ mental health status was measured using the Positive And Negative Syndrome Scale (PANSS; Kay et al. 1989), the Global Assessment of Functioning (GAF; American Psychiatric Association, 2002) and the Montgomery–Åsberg Depression Rating Scale (MADRS; Montgomery & Åsberg, 1979).”
MethodSAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02093.x · Cited by 13,597 · cited 2×
“Current alcohol, smoking and cannabis use was recorded using the following measures: the Alcohol Use Disorders Identification Test (AUDIT; Saunders et al. 1993); the Nicotine Dependence Questionnaire (Fagerstrom, 1978; Fagerstrom & Schneider, 1989); Timeline Follow-Back (Sobell & Sobell, 1992); and a urine drug screen.”
MethodGrundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961 · cited 1×
“Additionally, we also determined if each patient met the adapted National Cholesterol Education Program (NCEP) Third Adult Treatment Panel (ATP-III) criteria (NCEP ATP-III criteria) (Grundy et al. 2005), to allow for comparison with selected studies.”
MethodSelf-citationThe metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · cited 2×
“The IDF definitions of other cardiometabolic risk factors and of the MetS were used (see Table 1) (Alberti et al. 2005, 2006).”
BackgroundMethodAlberti, K. G. M. M., Zimmet, P., & Shaw, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01858.x · Cited by 6,597 · cited 1×
“The IDF definitions of other cardiometabolic risk factors and of the MetS were used (see Table 1) (Alberti et al. 2005, 2006).”
MethodGlobal and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 2×
“Although central obesity is known tobe thebest predictorofmorbidityandmortality (Zimmet et al. 2001), waist circumference has not to date been routinely measured in people with psychosis, although it has now been included in the latest National Institute of Health and Clinical Excellence (2014) guidelines for schizoph…”
BackgroundSobell, L. C., & Sobell, M. B. (1992) · Measuring Alcohol Consumption · doi:10.1007/978-1-4612-0357-5_3 · Cited by 4,110 · cited 3×
“Current alcohol, smoking and cannabis use was recorded using the following measures: the Alcohol Use Disorders Identification Test (AUDIT; Saunders et al. 1993); the Nicotine Dependence Questionnaire (Fagerstrom, 1978; Fagerstrom & Schneider, 1989); Timeline Follow-Back (Sobell & Sobell, 1992); and a urine drug screen.”
MethodInternational Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Walker, E. R., McGee, R. E., & Druss, B. G. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2502 · Cited by 2,976 · cited 2×
“75) times that of the general population, and higher rates of mortality for those with psychoses when compared with depressive and anxiety disorders (Walker et al. 2015).”
BackgroundInfluential
Research works printed but not linked: 8
- 2012, The Abandoned Illness: A Report by the Schizophrenia Commission
- 2014, National Institute of Health and Clinical Excellence: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care
- 2013, IDF Diabetes Atlas
- 2013, Statistics on Smoking: England, 2013
- 2002, Diagnostic and Statistical Manual of Mental Disorders
- Craig, 2011, Health Survey for England 2010
- 2012, Report of the National Audit of Schizophrenia
- Lester, 2014, Positive Cardiometabolic Health Resource: an Intervention Framework for Patients with Psychosis on Antipsychotic Medication
Cited by
Sorted by citations
Vancampfort, D., Correll, C. U., Galling, B., Probst, M., De Hert, M., Ward, P. B., Rosenbaum, S., Gaughran, F., Lally, J., & Stubbs, B. (2016) · World Psychiatry · doi:10.1002/wps.20309 · Cited by 659
Self-citationBarnes, T. R. E., Drake, R., Paton, C., Cooper, S. J., Deakin, J. F. W., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I. R., et al. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 615
Firth, J., Rosenbaum, S., Stubbs, B., Gorczynski, P., Yung, A. R., & Vancampfort, D. (2016) · Psychological Medicine · doi:10.1017/s0033291716001732 · Cited by 577
Stubbs, B., Firth, J., Berry, A., Schuch, F. B., Rosenbaum, S., Gaughran, F., Veronesse, N., Williams, J., Craig, T., Yung, A. R., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.05.017 · Cited by 379
Self-citationHow sedentary are people with psychosis? A systematic review and meta-analysis
Stubbs, B., Williams, J., Gaughran, F., & Craig, T. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.034 · Cited by 284
“, 2015b) and cardiovascular disease (Gardner-Sood et al., 2015) in peoplewith psychosis are of great concern.”
Self-citationRobinson, D. J., Coons, M., Haensel, H., Vallis, M., & Yale, J.-F. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.031 · Cited by 209
An Examination of Polygenic Score Risk Prediction in Individuals With First-Episode Psychosis
Vassos, E., Forti, M. D., Coleman, J. R. I., Iyegbe, C. O., Prata, D. P., Euesden, J., O’Reilly, P. F., Curtis, C. J. C., Kolliakou, A., Patel, H., et al. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.06.028 · Cited by 203
“Other/Mixed Ethnicity 69 (16) 27 (10) 27 (10) 0”
MethodSelf-citationPatel, C. A., Émond, B., Lafeuille, M., Côté‐Sergent, A., Lefèbvre, P., Tandon, N., & Khoury, A. C. E. (2019) · Drugs - Real World Outcomes · doi:10.1007/s40801-019-00172-9 · Cited by 185
Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study
Westman, J., Eriksson, S. V., Gissler, M., Hällgren, J., Prieto, M. L., Bobo, W. V., Frye, M. A., Erlinge, D., Alfredsson, L. S., & Ösby, U. (2017) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796017000166 · Cited by 171
“People who have schizophrenia are more likely to have more than one major risk factor for CVDs; namely, overweight, smoking, high blood pressure and the metabolic syndrome (Deuschle et al. 2013; Gardner-Sood et al. 2015; Olsson et al. 2015; Gutiérrez-Rojas et al. 2016).”
BackgroundStubbs, B., Koyanagi, A., Veronese, N., Vancampfort, D., Solmi, M., Gaughran, F., Carvalho, A. F., Lally, J., Mitchell, A. J., Mugisha, J., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0734-z · Cited by 151
“Recent studies have demonstrated that people with psychosis are at greatly increased risk of cardiovascular disease [4], metabolic syndrome [5], diabetes [6], and respiratory disease [7], and that these risks are especially increased compared to similarly aged healthy populations [8, 9].”
BackgroundSelf-citationTreatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics
Lally, J., Gaughran, F., Timms, P. W., & Curran, S. R. (2016) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s115741 · Cited by 133
Self-citationFirth, J., Stubbs, B., Vancampfort, D., Schuch, F. B., Rosenbaum, S., Ward, P. B., Firth, J. A., Sarris, J. J., & Yung, A. R. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx149 · Cited by 93
Ashdown‐Franks, G., Williams, J., Vancampfort, D., Firth, J., Schuch, F. B., Hubbard, K., Craig, T., Gaughran, F., & Stubbs, B. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.06.058 · Cited by 93
Self-citationRossom, R. C., Hooker, S. A., O’Connor, P. J., Crain, A. L., & Sperl‐Hillen, J. M. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.021444 · Cited by 86
“This prevalence of obesity in patients with SMI is in line with other studies 17– 20 that have reported rates generally ranging from 40% to 55%.”
Krivoy, A., Onn, R., Vilner, Y., Hochman, E., Weizman, S., Paz, A., Hess, S., Sagy, R., Kamhi-Nesher, S., Kalter, E., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.11.027 · Cited by 86
“, 2016) and consists mainly of metabolic syndrome(De et al., 2009c; Gardner-Sood et al., 2015; Vancampfort et al., 2015) that leads to a higher rate of cardiovascular morbidity(Correll et al.”
BackgroundRobinson, D. J., Hanson, K., Jain, A. B., Kichler, J. C., Mehta, G., Melamed, O. C., Vallis, M., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.04.009 · Cited by 73
Ilyas, A., Chesney, E., & Patel, R. (2017) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.117.203240 · Cited by 76
Netz, Y. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00257 · Cited by 69
“, 2017), which may cause cardiovascular diseases and metabolic syndromes (Gardner-Sood et al., 2015).”
BackgroundInfluentialZuelli, F. M. D. G. C., Brognara, F., Quirino, G. F. S., Hiroki, C. H., Fais, R. S., Del‐Ben, C. M., Ulloa, L., Salgado, H. C., Kanashiro, A., & Loureiro, C. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00618 · Cited by 73
Stubbs, B., Williams, J., Shannon, J., Gaughran, F., & Craig, T. (2016) · International Journal of Mental Health Nursing · doi:10.1111/inm.12256 · Cited by 56
Self-citationRingen, P. A., Færden, A., Antonsen, B. T., Falk, R. S., Mamen, A., Rognli, E. B., Solberg, D. K., Andreassen, O. A., & Martinsen, E. W. (2018) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2018.1449012 · Cited by 56
“A recent English study however, with 450 randomly selected patients with established (multi-episode) psychosis in both urban and rural community mental health teams, showed cardiometabolic risk factor levels similar to the current study [41].”
BackgroundThe Effects of Anhedonia in Social Context
Barkus, E. (2021) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-021-00232-x · Cited by 61
Clinical correlates of vitamin D deficiency in established psychosis
Lally, J., Gardner-Sood, P., Firdosi, M., Iyegbe, C. O., Stubbs, B., Greenwood, K., Murray, R. M., Smith, S. M., Howes, O. D., & Gaughran, F. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0780-2 · Cited by 56
“cardiovascular risk, MetS [9, 10] and type 2 diabetes mellitus [11] which are leading contributors to premature mortality in this population [12].”
BackgroundSelf-citationLi, Q., Du, X., Zhang, Y., Yin, G., Zhang, G., Walss‐Bass, C., Quevedo, J., Soares, J. C., Xia, H., Li, X., et al. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.12.041 · Cited by 52
Maripuu, M., Bendix, M., Öhlund, L., Widerström, M., & Werneke, U. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.609579 · Cited by 46
on behalf of the IMPaCT Team, Gaughran, F., Stahl, D. R., Ismail, K., Greenwood, K., Atakan, Z., Gardner-Sood, P., Stubbs, B., Hopkins, D., Patel, A. K., et al. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1571-0 · Cited by 49
“Thus it attempted to meet the needs of this very hard-to-reach group with high rates of cardiometabolic disease [7] by enhancing routine care.”
BackgroundResultInfluentialSelf-citationBueno‐Antequera, J., & Munguía‐Izquierdo, D. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1792-1_21 · Cited by 47
Gur, S., Weizman, S., Stubbs, B., Matalon, A., Meyerovitch, J., Hermesh, H., & Krivoy, A. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.11.042 · Cited by 42
Saloojee, S., Burns, J. K., & Motala, A. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149209 · Cited by 42
“Reported prevalence rates range from 9.3% in Indonesia [8] to 21% in Mexico [9], 27.5% in Japan [10], 57% in England [11] and 68% in Australia [12].”
BackgroundInfluentialImmune and metabolic alterations in first episode psychosis (FEP) patients
Bocchio‐Chiavetto, L., Zanardini, R., Tosato, S., Ventriglia, M., Ferrari, C., Bonetto, C., Lasalvia, A., Giubilini, F., Fioritti, A., Pileggi, F., et al. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.03.013 · Cited by 42
Loneliness in psychotic illness and its association with cardiometabolic disorders
Badcock, J. C., Mackinnon, A. J., Waterreus, A. J., Watts, G. F., Castle, D. J., McGrath, J. J., & Morgan, V. A. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.09.021 · Cited by 43
Williams, J., Stubbs, B., Richardson, S., Flower, C., Barr-Hamilton, L., Grey, B., Hubbard, K., Spaducci, G., Gaughran, F., & Craig, T. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2274-5 · Cited by 44
Self-citationGómez, L., Stubbs, B., Ayala, S., Vancampfort, D., Gaughran, F., & Lally, J. (2016) · Current Osteoporosis Reports · doi:10.1007/s11914-016-0325-0 · Cited by 40
Self-citationvan der Stouwe, E. C. D., van Busschbach, J. T., de Vries, B., Cahn, W., Aleman, A., & Pijnenborg, G. H. M. (2018) · NeuroImage Clinical · doi:10.1016/j.nicl.2018.04.018 · Cited by 43
“…of schizophrenia spectrum disorders concerns the fact that the use of anti-psychotic medication, but also the disorder in itself, are associated with metabolic symptoms (Mitchell et al., 2013), such as type two diabetes (Stubbs et al., 2015) and cardiovascular disease (Gardner-Sood et al., 2015).”
BackgroundTobacco smoking and nicotine dependence in first episode and established psychosis
Lally, J., Spaducci, G., Gardner-Sood, P., Atakan, Z., Greenwood, K., Forti, M. D., Ismail, K., Murphy, K. C., Smith, S. M., McNeill, A. D., et al. (2019) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2019.05.002 · Cited by 37
Self-citationCrosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction
Goh, K. K., Chen, C. Y.-A., Wu, T., Chen, C.-H., & Lu, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137092 · Cited by 41
“Persons with schizophrenia demonstrate several hallmark features of metabolic syndrome conditions that increase cardiometabolic risk [109,110].”
BackgroundMartland, R., Teasdale, S. B., Murray, R. M., Gardner-Sood, P., Smith, S. M., Ismail, K., Atakan, Z., Greenwood, K., Stubbs, B., & Gaughran, F. (2021) · Psychological Medicine · doi:10.1017/s0033291721003147 · Cited by 38
“Dietary intake and behaviour patterns of the IMPaCT sample have been previously reported (Gardner-Sood et al., 2015; Gaughran et al., 2017) although longitudinal results have not been reported, and no correlational analyses between these factors and mental health symptomology, and global function,…”
BackgroundMethodResultInfluentialSelf-citationTackling mental health: the role of professional football clubs
Curran, K., Rosenbaum, S., Parnell, D., Stubbs, B., Pringle, A., & Hargreaves, J. (2016) · Sport in Society · doi:10.1080/17430437.2016.1173910 · Cited by 32
Filipčić, I. Š., Filipcic, I. S., Ivezić, E., Matić, K., Vukadinovic, N. T., Pisk, S. V., Bodor, D., Bajić, Ž., Jakovljević, M., & Sartorius, N. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.02.484 · Cited by 30
“Growing body of evidence has demonstrated that people with psychosis are at greatly increased risk of chronic physical comorbidities (cardiovascular disease, metabolic syndrome, diabetes, and respiratory disease) [10,11].”
BackgroundCardiometabolic Risk in First Episode Psychosis Patients
Smith, J., Griffiths, L., Band, M., & Horne, D. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.564240 · Cited by 29
Dixon, K., Belshaw, D., Johnson, P., & Flynn, D. (2018) · Sport in Society · doi:10.1080/17430437.2018.1514014 · Cited by 28
Gaughran, F., Stahl, D. R., Stringer, D., Hopkins, D., Atakan, Z., Greenwood, K., Patel, A. K., Smith, S. M., Gardner-Sood, P., Lally, J., et al. (2019) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.159 · Cited by 28
Self-citationvan Genk, C., Roeg, D. P. K., van Vugt, M., van Weeghel, J., & Regenmortel, T. V. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1156235 · Cited by 37
“This builds on previous research that shows that people with SMI experience premature mortality of around 15–20 years earlier than the general population (88), have a high prevalence of substance use disorder (89), and are at risk of the development of often preventable secondary health conditions (90, 91).”
MethodDisordered eating behaviors as a potential obesogenic factor in schizophrenia
Kouidrat, Y., Amad, A., Stubbs, B., Louhou, R., Renard, N., Diouf, M., Lalau, J., & Loas, G. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.083 · Cited by 26
“…lifestyle factors (poor diet, low levels of physical activity, substances abuse, high rates of smoking), antipsychotic medications side effects and genetic predisposition (De Hert et al., 2012; Gardner-Sood et al., 2015; Kouidrat et al., 2013; Malan-Müller et al., 2016; Stubbs et al., 2016).”
BackgroundAgaba, D. C., Migisha, R., Namayanja, R., Katamba, G., Lugobe, H. M., Aheisibwe, H., Twesigomwe, G., & Ashaba, S. (2019) · BioMed Research International · doi:10.1155/2019/1096201 · Cited by 24
Fenger‐Grøn, M., Vestergaard, C. H., Ribe, A. R., Johnsen, S. P., Frost, L., Sandbæk, A., & Davydow, D. S. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.10096 · Cited by 24
Roberts, E., Jones, L., Blackman, A., Dewhurst, T., Matcham, F., Kan, C., Mustafa, O., Thomas, T., Siddiqi, N., Ismail, K., et al. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.01.003 · Cited by 23
Self-citationShared and unique characteristics of metabolic syndrome in psychotic disorders: a review
Saccaro, L. F., Aimo, A., Panichella, G., & Sentissi, O. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1343427 · Cited by 30
Heald, A., Martin, J. L., Payton, T., Khalid, L., Anderson, S., Narayanan, R., de Hert, M., Yung, A., & Livingston, M. (2017) · Australian and New Zealand journal of psychiatry (Print) · doi:10.1177/0004867415625817 · Cited by 26
“As the background population prevalence of obesity and type 2 diabetes has increased dramatically over the past couple of decades, this increase has similarly been observed in individuals with SMI (Gardner-Sood et al., 2015; Holt and Peveler, 2009; Mitchell et al., 2013).”
BackgroundRozing, M. P., Jønsson, A. B. R., Køster‐Rasmussen, R., Due, T. D., Brodersen, J., Bissenbakker, K. H., Siersma, V., Mercer, S. W., Guassora, A. D., Kjellberg, J., et al. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-021-00906-z · Cited by 20
Berry, A., Drake, R., Webb, R. T., Ashcroft, D. M., Carr, M., & Yung, A. R. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00685 · Cited by 20
Hubbard, G., Thompson, C. W., Locke, R., Jenkins, D., Munoz, S.-A., van Woerden, H. C., Maxwell, M., Yang, Y., & Gorely, T. (2020) · BMC Public Health · doi:10.1186/s12889-020-08518-7 · Cited by 20
Bressington, D. T., Chien, W. T., Mui, J. H. C., Lam, K. K. C., Mahfoud, Z. R., White, J., & Gray, R. J. (2017) · International Journal of Mental Health Nursing · doi:10.1111/inm.12373 · Cited by 21
“© 2017 Australian College of Mental Health Nurses Inc. respiratory conditions (Gardner-Sood et al. 2015; Robson & Gray 2007; Vancampfort et al. 2015).”
BackgroundHealthcare cost, service use and mortality in major psychiatric disorders in Taiwan
Pan, Y., Kuo, K., & Yeh, L. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.046 · Cited by 21
Transformation of excess mortality in people with schizophrenia and bipolar disorder in Taiwan
Pan, Y., Yeh, L., Chan, H.-Y., & Chang, C. (2017) · Psychological Medicine · doi:10.1017/s0033291717001040 · Cited by 20
“…2011), stressing the potential relevance of sedentary lifestyles, smoking, obesity, adverse effects of medications, and inadequate health services delivered to those with SMI (Lahti et al. 2012; Laursen et al. 2014; Morgan et al. 2014; Gardner-Sood et al. 2015), to the gap in the excess mortality.”
BackgroundRichardson, A., Richard, L., Gunter, K. E., & Derrett, S. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031122 · Cited by 24
Sudarshan, Y., & Cheung, B. M. Y. (2022) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2021-141386 · Cited by 23
Williams, J., Stubbs, B., Gaughran, F., & Craig, T. (2016) · Trials · doi:10.1186/s13063-016-1660-2 · Cited by 19
“using mental health services in which researchers found that nearly all women and most men had a waist circumference exceeding the International Diabetes Federation (IDF) threshold for central obesity, with the half of the sample being obese, one-fifth meeting the criteria for type 2 diabetes mellitus (T2DM) and 57 %…”
MethodInfluentialSelf-citationLiu, Z., Zhang, Y., Zhao, T., Wang, J., Xia, L., Zhong, Y., Yang, Y., Ning, X., Zhang, Y., Ren, Z., et al. (2020) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2020.1755995 · Cited by 18
Kwobah, E. K., Koen, N., Mwangi, A., Atwoli, L., & Stein, D. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245086 · Cited by 17
“In this study we found; 1] A high prevalence of DM, HTN, dyslipidemia, obesity and metabolic syndrome in patients with psychosis,; [2] A particular risk profile for metabolic syndrome; and [3] gaps in documented treatment for patients with diabetes, hypertension and dyslipidemia.”
BackgroundVázquez-Bourgón, J., Gómez‐Revuelta, M., Son, J. M.-V., Labad, J., de la Foz, V. O., Setién‐Suero, E., Ayesa‐Arriola, R., Tordesillas‐Gutiérrez, D., Juncal‐Ruíz, M., & Crespo‐Facorro, B. (2022) · European Psychiatry · doi:10.1192/j.eurpsy.2022.2308 · Cited by 17
“[11] reported in a group of 450 participants with chronic psychosis that half of them were obese, and 57% met criteria for metabolic syndrome, while a fifth met the criteria for type 2 diabetes mellitus.”
BackgroundLally, J., Loughlin, A. O., Stubbs, B., Guérandel, A., O'Shea, D. B., & Gaughran, F. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1445968 · Cited by 18
Self-citationChen, P., Chang, C., Chen, C.-H., Fang, S., Mondelli, V., Chiu, C., Lu, M., Hwang, L.-L., & Huang, M. (2022) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2022.03.008 · Cited by 15
Taylor, J., Boehnke, J. R., Wright, J. M., Kellar, I., Alderson, S. L., Hughes, T. E., Holt, R. I. G., & Siddiqi, N. (2017) · Trials · doi:10.1186/s13063-017-1805-y · Cited by 16
Heslin, M., Patel, A., Stahl, D., Gardner-Sood, P., Mushore, M., Smith, S., Greenwood, K., Onagbesan, O., O'Brien, C., Fung, C., et al. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1570-1 · Cited by 15
“13South London and Maudsley NHS Foundation Trust, London, UK.”
BackgroundInfluentialSelf-citationGal, G., Munitz, H., & Levav, I. (2015) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796015000852 · Cited by 15
“Accumulative evidence has pointed out that risk factors for CVD are more common in persons with schizophrenia (De Hart et al. 2009; Gardner-Sood et al. 2015).”
BackgroundLeyland, S., Currie, A., Anderson, S., Bradley, E., & Ling, J. (2018) · Mental health and physical activity · doi:10.1016/j.mhpa.2018.05.002 · Cited by 14
Westman, J., Eberhard, J., Gaughran, F., Lundin, L., Stenmark, R., Edman, G., Eriksson, S. V., Jedenius, E., Rydell, P., Overgaard, K., et al. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.03.026 · Cited by 12
“Metabolic risk factors for CVD, such as central obesity, glucose dysregulation, hypertension, and dyslipidemia are highly prevalent in people with psychotic disorders (Gardner-Sood et al., 2015; Olsson et al., 2015).”
BackgroundSelf-citationPatel, D., Msosa, Y. J., Wang, T., Mustafa, O. G., Gee, S., Williams, J., Roberts, A., Dobson, R., & Gaughran, F. (2022) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-022-01842-5 · Cited by 12
“[6] Rates of diabetes in the South London area of the UK amongst people with a diagnosis of established psychosis are 20% with a further 30% evidencing dysglycaemia which refers to raised blood sugar levels [7].”
BackgroundSelf-citationIdeal Cardiovascular Health in Racially and Ethnically Diverse People with Serious Mental Illness
Hawes, M. R., Roth, K. B., Wang, X., Stefancic, A., Weatherly, C., & Cabassa, L. J. (2020) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2020.0126 · Cited by 12
Fentie, D., & Yibabie, S. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03327-3 · Cited by 11
“According to studies, people with prevalent mental disorders are more likely to have dyslipidemia [4].”
BackgroundLurie, I., Shoval, G., Hoshen, M., Balicer, R. D., Weiser, M., Weizman, A., & Krivoy, A. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.08.019 · Cited by 11
Gaughran, F., Stringer, D., Berk, M., Smith, S. M., Taylor, D. M., Whiskey, E., Landau, S., Murray, R. M., McGuire, P. K., Gardner-Sood, P., et al. (2020) · Trials · doi:10.1186/s13063-019-3758-9 · Cited by 11
Self-citationThe role of physical pain in global functioning of people with serious mental illness
Abplanalp, S. J., Mueser, K. T., & Fulford, D. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.03.062 · Cited by 9
Chen, Y.-H., Wang, H., Lang, X., & Zhang, X. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115250 · Cited by 10
Melzer, D. R., Delgado, J., Winder, R. E., Masoli, J. A. H., Richards, S. H., & Blè, A. (2015) · Cited by 10
Jensen, K. T., Colnadar, B., Nielsen, M. H., Hjorthøj, C. R., & Møller, A. (2024) · BMC Family Practice · doi:10.1186/s12875-024-02504-3 · Cited by 9
“The lower average life expectancy can, in addition to suicidal behaviour and overdose, be largely attributed to an increased risk of several chronic health conditions [3, 6, 10–14], with cardiovascular disorders reported as being the greatest risk [15].”
BackgroundNadal, I. P., Cliffton, C., Chamley, M., Winkley, K., Gaughran, F., & Ismail, K. (2019) · Health & Social Care in the Community · doi:10.1111/hsc.12903 · Cited by 9
Self-citationTessem, S., Møyner, E., & Feiring, M. (2021) · Physiotherapy Theory and Practice · doi:10.1080/09593985.2021.1878566 · Cited by 10
Ashdown‐Franks, G., deJonge, M. L., Arbour‐Nicitopoulos, K. P., & Sabiston, C. M. (2022) · Qualitative Research in Sport Exercise and Health · doi:10.1080/2159676x.2021.2019098 · Cited by 10
de Vries, B., van der Stouwe, E. C. D., Waarheid, C. O., Poel, S. H. J., van der Helm, E., Aleman, A., Arends, J., Pijnenborg, G. H. M., & van Busschbach, J. T. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1958-6 · Cited by 9
Prevalence and associations of fatigue in psychosis: A systematic review and meta-analysis
Poole-Wright, K., Patel, A., Gaughran, F., Murray, R. M., & Chalder, T. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.03.027 · Cited by 8
Self-citationDouble disparities in the health care for people with schizophrenia of an ethnic-national minority
Gal, G., Munitz, H., & Levav, I. (2017) · Israel Journal of Health Policy Research · doi:10.1186/s13584-017-0166-z · Cited by 8
“Accumulative evidence has pointed out that risk factors for CVD are more common in persons with schizophrenia [43, 44].”
BackgroundGaughran, F., Stahl, D. R., Patel, A. K., Ismail, K., Smith, S. M., Greenwood, K., Atakan, Z., Gardner-Sood, P., Stringer, D., Hopkins, D., et al. (2020) · Programme Grants for Applied Research · doi:10.3310/pgfar08010 · Cited by 9
Self-citationGardner-Sood, P., Lally, J., Smith, S. M., Atakan, Z., Ismail, K., Greenwood, K., Keen, A., O’Brien, C., Onagbesan, O. M., Fung, C., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715001154 · Cited by 8
“The author regrets to announce that affiliation 8, in the above article (Gardner-Sood et al. 2015), contained an error in the author affiliation address and author surname, which were published in the approved article.”
BackgroundSelf-citationEnd-of-life care for people with severe mental illness: the MENLOC evidence synthesis
Hannigan, B., Edwards, D. J., Anstey, S., Coffey, M., Gill, P., Mann, M. K., & Meudell, A. (2022) · Health and Social Care Delivery Research · doi:10.3310/ulti9178 · Cited by 7
Tsima, B. M., Opondo, P. R., Mosepele, M., Mautle, E., Bilker, W. B., & Gross, R. (2022) · BMC Cardiovascular Disorders · doi:10.1186/s12872-022-02939-5 · Cited by 7
Berry, A., Drake, R., Butcher, I., & Yung, A. R. (2021) · Mental health and physical activity · doi:10.1016/j.mhpa.2021.100415 · Cited by 9
Yang, C., Zhong, X., Zhou, H., Wu, Z., Zhang, M., & Ning, Y. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s261223 · Cited by 7
Wu, G., Dong, Z., Li, Z., Zhao, Q., Chen, S., Dong, Q., Huang, L., Zhang, Y., Wang, X., Chen, S., et al. (2025) · Schizophrenia · doi:10.1038/s41537-025-00646-6 · Cited by 7
“Meta-analyses indicate that the prevalence of hypertension in SCZ patients is approximately 39%, and nearly one-third of individuals meet the diagnostic criteria for metabolic syndrome 7,8 .”
Vitamin D deficiency in schizophrenia implications for COVID-19 infection
Walsh, D. V., Kennedy-Williams, S., Taylor, D. M., Gaughran, F., & Lally, J. (2020) · Irish Journal of Psychological Medicine · doi:10.1017/ipm.2020.107 · Cited by 6
“Patients with schizophrenia have a higher burden of the risk factors identified above (Gardner-Sood et al. 2015; Gaughran et al. 2019; Lally, Spaducci, et al. 2019), leaving them more vulnerable to adverse outcomes of infection.”
BackgroundSelf-citationRisk factors for metabolic and cardiovascular disease in inpatients with severe mental illness
Lavagnino, L., Gurguis, C. I., & Lane, S. D. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.114148 · Cited by 7
Schulte, E. C., & Schulze, T. G. (2024) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.02.007 · Cited by 6
Exercise as an Adjuvant Treatment of Schizophrenia: A Review
Abbas, M. S., Nassar, S. T., Tasha, T., Desai, A. V., Bajgain, A., Ali, A., Dutta, C., Pasha, K., Paul, S., & Venugopal, S. (2023) · Cureus · doi:10.7759/cureus.42084 · Cited by 5
“In fact, the prevalence of the metabolic syndrome is twice in patients being treated with antipsychotics [4], and physical activity proves to manage these adverse effects of antipsychotics.”
BackgroundAntipsychotics and Mortality in Adult and Geriatric Patients with Schizophrenia
Yeh, L., Lee, W., Kuo, K., & Pan, Y. (2023) · Pharmaceuticals · doi:10.3390/ph17010061 · Cited by 7
“…of all deaths among such individuals are classified as occurring due to natural causes [1], and research indicates that a sedentary lifestyle, obesity, limited access to health services, and the adverse effects of medications [7–10] may contribute to this population’s high mortality rates.”
BackgroundCocoman, A. M., & Gallagher, D. (2019) · Issues in Mental Health Nursing · doi:10.1080/01612840.2019.1609636 · Cited by 5
“Irish authors Gubbins et al. (2012) reported on individuals prescribed clozapine at 46.4%, while, in the United Kingdom Gardner-Sood et al. (2015) reported rates of 56.2%.”
BackgroundInfluentialUndiagnosed disease in decedents with and without schizophrenia: an autopsy-based case-control study
Puntervold, O. E., Kruckow, L., & Banner, J. (2021) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2021.1905877 · Cited by 5
“potentially adjustable risk factors, such as substance use, obesity and poor lifestyle [15,42,43,46,49,53,54].”
BackgroundWilliams, J., Fairbairn, E., McGrath, R., Bakolis, I., Healey, A., Akpan, U., Mdudu, I., Gaughran, F., Sadler, E., Khadjesari, Z., et al. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-021-00854-8 · Cited by 5
Self-citationMeepring, S., Gray, R. J., Li, Y., Ho, G. W. K., Chien, W. T., & Bressington, D. T. (2021) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12809 · Cited by 5
Huck, G. E., Finnicum, C. A., Morrison, B., Kaseroff, A. A., & Umucu, E. (2018) · Psychiatric Rehabilitation Journal · doi:10.1037/prj0000311 · Cited by 5
Metadata
- Authors
- Gardner-Sood, P., Lally, J., Smith, S., Atakan, Z., Ismail, K., Greenwood, K. E., Keen, A., O'Brien, C., Onagbesan, O., Fung, C., Papanastasiou, E., Eberherd, J., Patel, A., Ohlsen, R., Stahl, D., David, A., Hopkins, D., Murray, R. M., Gaughran, F., & on behalf of the IMPaCT team
- Affiliations
- King's College London (GB)
- National Health Service (GB)
- University of Sussex (GB)
- Corresponding author
- Gaughran, F.
- ORCID
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2015-05-12
- Volume
- 45
- Issue
- 12
- Pages
- 2619-2629
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- PMC
- PMC4531468
- OpenAlex
- W2166495311
- Semantic Scholar
- 487ef347e280ef3e816147fd31590df2a7dd7e33
- Cited by
- 140
- References
- 64
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 12 · 2021: 17 · 2020: 13 · 2019: 13 · 2018: 21 · 2017: 15 · 2016: 18 · 2015: 3
- FWCI
- 15.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Psychological Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion)
- Research Portal (King's College London) (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by)
- Funders
- South London and Maudsley NHS Foundation Trust
- National Institute for Health and Care Research (0606-1049, RP-PG-0606-1049, PG-0606-1049)
- King's College London
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- metabolic syndrome, psychosis, cardiometabolic risk factors, obesity, abdominal obesity, type 2 diabetes, waist circumference, sex differences, disease severity, functional disability, lifestyle habits, IMPACT trial
- MeSH terms
- Adolescent, Adult, Aged, Mental Disorders, Benzodiazepines, Cardiovascular Diseases, Community Mental Health Centers, Diabetes Mellitus, Type 2, England, Female, Humans, Male, Middle Aged, Obesity, Risk Factors, Rural Population, State Medicine, Urban Population, Prevalence, Sex Distribution, Metabolic Syndrome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
